TYROSINE KINASE INHIBITORS (TKI) FOR THE TREATMENT OF ADVANCED MEDULLARY THYROID CARCINOMA: A SYSTEMATIC REVIEW AND INDIRECT COMPARISON

被引：0
|
作者：
Kawalec, P. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN4
引用
收藏
页码：A708 / A708
页数：1
相关论文
共 50 条
  • [21] Tyrosine Kinase Inhibitors in Advanced Renal Cell Carcinoma: The Evolving Treatment Paradigm
    Bukowski, Ronald M.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 9 - 10
  • [22] Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
    Vasudev, Naveen S.
    Larkin, James M. G.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 333 - 342
  • [23] Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia
    Cvetka Grasic Kuhar
    Taja Lozar
    Nikola Besic
    Maja Music Marolt
    Advances in Therapy, 2021, 38 : 5684 - 5699
  • [24] Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in Slovenia
    Grasic Kuhar, Cvetka
    Lozar, Taja
    Besic, Nikola
    Music Marolt, Maja
    ADVANCES IN THERAPY, 2021, 38 (12) : 5684 - 5699
  • [25] Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
    Saronni, Davide
    Gaudenzi, Germano
    Dicitore, Alessandra
    Carra, Silvia
    Cantone, Maria Celeste
    Borghi, Maria Orietta
    Barbieri, Andrea
    Mignani, Luca
    Hofland, Leo J.
    Persani, Luca
    Vitale, Giovanni
    CANCERS, 2022, 14 (18)
  • [26] Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors" - Reply
    Moley, JF
    SURGERY, 2004, 135 (02) : 241 - 241
  • [27] Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib
    Kawalec, Pawel
    Malinowska-Lipien, Iwona
    Brzostek, Tomasz
    Kozka, Maria
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (12) : 1303 - 1309
  • [28] Systemic treatment of advanced, metastatic, medullary thyroid carcinoma
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Cappagli, Virginia
    Lorusso, Loredana
    Bottici, Valeria
    Elisei, Rossella
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [29] Procalcitonin for detecting medullary thyroid carcinoma: a systematic review
    Trimboli, Pierpaolo
    Seregni, Ettore
    Treglia, Giorgio
    Alevizaki, Maria
    Giovanella, Luca
    ENDOCRINE-RELATED CANCER, 2015, 22 (03) : R157 - R164
  • [30] A SYSTEMATIC REVIEW OF TYROSINE KINASE INHIBITORS AS FIRST LINE TREATMENT FOR ADVANCED NON SMALL CELL LUNG CANCER
    Kamaruzaman, H. F.
    Abd Rahim, Ku K. N.
    Lee, S. W.
    Darus, Mohd N.
    Sabirin, J.
    VALUE IN HEALTH, 2016, 19 (07) : A885 - A885
12345